A phase IIa study of rhLTα-Da in combination with cisplatin and fluorouracil for patients with metastatic esophageal squamous cell carcinoma or gastric adenocarcinoma.
about
A phase IIa study of rhLTα-Da in combination with cisplatin and fluorouracil for patients with metastatic esophageal squamous cell carcinoma or gastric adenocarcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A phase IIa study of rhLTα-Da ...... oma or gastric adenocarcinoma.
@en
type
label
A phase IIa study of rhLTα-Da ...... oma or gastric adenocarcinoma.
@en
prefLabel
A phase IIa study of rhLTα-Da ...... oma or gastric adenocarcinoma.
@en
P2093
P2860
P1433
P1476
A phase IIa study of rhLTα-Da ...... oma or gastric adenocarcinoma.
@en
P2093
Feng-Hua Wang
Feng-Zhan Qin
Jian-Hua Chen
Wen-Qi Jiang
Zhen-Dong Chen
P2860
P2888
P356
10.1007/S12032-016-0846-5
P50
P577
2016-10-14T00:00:00Z
P6179
1048558654